drugs Archives – Cambridge Enterprise

Polyproxin® molecules

PolyProx Therapeutics: a new class of drugs to halt difficult-to-drug cancers

27 February 2020 • 3 min read

Seed Fund Investment Manager on BioBeat’s 2018 list of 50 Female Movers and Shakers

01 November 2018 • 6 min read

Making medicine simple

04 October 2016 • 3 min read

Cambridge University allies with TeraView to boost drug formulation

18 May 2016 • 3 min read

PhoreMost raises £2.5m to identify new targets for therapeutics

08 April 2015 • 4 min read

XO1 crystal structure

Spin-out X01 acquired by Janssen

07 April 2015 • 2 min read

DefiniGEN stem cell research plays vital role in developing new drugs

16 February 2015 • 3 min read

Drugs

First of new generation of cancer drugs granted European approval

19 December 2014 • 4 min read

Cambridge academics win GSK’s Discovery Fast Track Challenge

01 December 2014 • 4 min read

Lynparza recommended for approval in ovarian cancer

24 October 2014 • 4 min read

Official opening of Cambridge labs at Stevenage Bioscience Catalyst

20 March 2014 • 4 min read

test tubes

Cambridge drug approved for treatment of multiple sclerosis

17 September 2013 • 4 min read